O	0	8	Elevated	Elevated	JJ	B-NP
O	9	15	levels	level	NNS	I-NP
O	16	18	of	of	IN	B-PP
O	19	33	diacylglycerol	diacylglycerol	NN	B-NP
O	34	37	and	and	CC	O
O	38	47	decreased	decrease	VBD	B-VP
O	48	55	phorbol	phorbol	NN	B-NP
O	56	61	ester	ester	NN	I-NP
O	62	73	sensitivity	sensitivity	NN	I-NP
O	74	76	in	in	IN	B-PP
O	77	80	ras	ras	NN	B-NP
O	80	81	-	-	HYPH	B-NP
O	81	92	transformed	transform	VBN	I-NP
B-Cell	93	104	fibroblasts	fibroblast	NNS	I-NP
O	104	105	.	.	.	O

O	107	121	Diacylglycerol	Diacylglycerol	NN	B-NP
O	122	123	(	(	(	O
O	123	125	DG	DG	NN	B-NP
O	125	126	)	)	)	O
O	127	132	plays	play	VBZ	B-VP
O	133	134	a	a	DT	B-NP
O	135	142	central	central	JJ	I-NP
O	143	147	role	role	NN	I-NP
O	148	150	in	in	IN	B-PP
O	151	163	phospholipid	phospholipid	NN	B-NP
O	164	174	metabolism	metabolism	NN	I-NP
O	175	178	and	and	CC	O
O	179	181	is	be	VBZ	B-VP
O	182	184	an	an	DT	B-NP
O	185	195	endogenous	endogenous	JJ	I-NP
O	196	205	activator	activator	NN	I-NP
O	206	208	of	of	IN	B-PP
O	209	216	protein	protein	NN	B-NP
O	217	223	kinase	kinase	NN	I-NP
O	224	225	C	C	NN	I-NP
O	225	226	.	.	.	O

O	227	229	We	We	PRP	B-NP
O	230	234	have	have	VBP	B-VP
O	235	244	suggested	suggest	VBN	I-VP
O	245	249	that	that	IN	B-SBAR
O	250	262	constitutive	constitutive	JJ	B-NP
O	263	273	activation	activation	NN	I-NP
O	274	276	of	of	IN	B-PP
O	277	281	this	this	DT	B-NP
O	282	288	kinase	kinase	NN	I-NP
O	289	291	is	be	VBZ	B-VP
O	292	295	one	one	CD	B-NP
O	296	305	mechanism	mechanism	NN	I-NP
O	306	308	by	by	IN	B-PP
O	309	314	which	which	WDT	B-NP
O	315	324	oncogenes	oncogene	NNS	B-NP
O	325	334	transform	transform	VBP	B-VP
B-Cell	335	340	cells	cell	NNS	B-NP
O	340	341	.	.	.	O

O	342	345	The	The	DT	B-NP
O	346	349	ras	ras	NN	I-NP
O	349	350	-	-	HYPH	B-NP
O	350	357	encoded	encode	VBN	I-NP
O	358	366	proteins	protein	NNS	I-NP
O	367	370	are	be	VBP	B-VP
O	371	378	similar	similar	JJ	B-ADJP
O	379	381	to	to	TO	B-PP
O	382	392	regulatory	regulatory	JJ	B-NP
O	393	394	G	G	NN	I-NP
O	394	395	-	-	HYPH	B-NP
O	395	403	proteins	protein	NNS	I-NP
O	404	407	and	and	CC	O
O	408	411	are	be	VBP	B-VP
O	412	422	candidates	candidate	NNS	B-NP
O	423	426	for	for	IN	B-PP
O	427	430	the	the	DT	B-NP
O	431	438	unknown	unknown	JJ	I-NP
O	439	440	G	G	NN	I-NP
O	440	441	-	-	HYPH	B-NP
O	441	448	protein	protein	NN	I-NP
O	449	453	that	that	WDT	B-NP
O	454	463	modulates	modulate	VBZ	B-VP
O	464	484	phosphatidylinositol	phosphatidylinositol	NN	B-NP
O	485	486	(	(	(	O
O	486	488	PI	PI	NN	B-NP
O	488	489	)	)	)	O
O	490	498	turnover	turnover	NN	B-NP
O	498	499	.	.	.	O

O	500	511	Differences	Difference	NNS	B-NP
O	512	514	in	in	IN	B-PP
O	515	535	polyphosphoinositide	polyphosphoinositide	NN	B-NP
O	536	546	metabolism	metabolism	NN	I-NP
O	547	551	have	have	VBP	B-VP
O	552	556	been	be	VBN	I-VP
O	557	565	reported	report	VBN	I-VP
O	566	569	for	for	IN	B-PP
O	570	573	ras	ras	NN	B-NP
O	573	574	-	-	HYPH	B-NP
O	574	585	transformed	transform	VBN	I-NP
B-Cell	586	591	cells	cell	NNS	I-NP
O	591	592	.	.	.	O

O	593	596	But	But	CC	O
O	597	604	because	because	IN	B-SBAR
O	605	610	these	these	DT	B-NP
O	611	622	experiments	experiment	NNS	I-NP
O	623	627	were	be	VBD	B-VP
O	628	637	performed	perform	VBN	I-VP
O	638	640	on	on	IN	B-PP
O	641	650	confluent	confluent	JJ	B-NP
B-Cell	651	659	cultures	culture	NNS	I-NP
O	660	662	of	of	IN	B-PP
O	663	674	established	establish	VBN	B-NP
B-Cell	675	679	cell	cell	NN	I-NP
I-Cell	680	685	lines	line	NNS	I-NP
O	685	686	,	,	,	O
O	687	690	the	the	DT	B-NP
O	691	702	differences	difference	NNS	I-NP
O	703	706	are	be	VBP	B-VP
O	707	716	difficult	difficult	JJ	B-ADJP
O	717	719	to	to	TO	B-VP
O	720	729	attribute	attribute	VB	I-VP
O	730	732	to	to	TO	B-PP
O	733	736	ras	ras	NN	B-NP
O	737	751	transformation	transformation	NN	I-NP
O	751	752	.	.	.	O

O	753	757	Here	Here	RB	B-ADVP
O	758	760	we	we	PRP	B-NP
O	761	765	show	show	VBP	B-VP
O	766	770	that	that	IN	B-NP
O	771	784	exponentially	exponentially	RB	B-VP
O	785	792	growing	grow	VBG	I-VP
B-Cell	793	796	NIH	NIH	NN	B-NP
I-Cell	797	800	3T3	3T3	NN	I-NP
I-Cell	801	812	fibroblasts	fibroblast	NNS	I-NP
O	813	821	recently	recently	RB	B-VP
O	822	833	transformed	transform	VBN	I-VP
O	834	836	by	by	IN	B-PP
O	837	839	Ha	Ha	NN	B-NP
O	839	840	-	-	HYPH	B-NP
O	840	843	ras	ras	NN	I-NP
O	844	846	or	or	CC	I-NP
O	847	849	Ki	Ki	NN	I-NP
O	849	850	-	-	HYPH	B-NP
O	850	853	ras	ras	NN	I-NP
O	854	861	possess	possess	NN	I-NP
O	862	870	elevated	elevate	VBD	B-VP
O	871	873	DG	DG	NN	B-NP
O	874	888	concentrations	concentration	NNS	I-NP
O	889	896	without	without	IN	B-PP
O	897	908	significant	significant	JJ	B-NP
O	909	920	alterations	alteration	NNS	I-NP
O	921	923	in	in	IN	B-PP
O	924	927	the	the	DT	B-NP
O	928	934	levels	level	NNS	I-NP
O	935	937	of	of	IN	B-PP
O	938	943	other	other	JJ	B-NP
O	944	964	polyphosphoinositide	polyphosphoinositide	NN	I-NP
O	965	976	metabolites	metabolite	NNS	I-NP
O	976	977	.	.	.	O

O	978	981	The	The	DT	B-NP
O	982	987	basal	basal	JJ	I-NP
O	988	1003	phosphorylation	phosphorylation	NN	I-NP
O	1004	1006	of	of	IN	B-PP
O	1007	1014	protein	protein	NN	B-NP
O	1015	1021	kinase	kinase	NN	I-NP
O	1022	1023	C	C	NN	I-NP
O	1024	1033	substrate	substrate	NN	I-NP
O	1034	1036	of	of	IN	B-PP
O	1037	1045	relative	relative	JJ	B-NP
O	1046	1055	molecular	molecular	JJ	I-NP
O	1056	1060	mass	mass	NN	I-NP
O	1061	1062	(	(	(	O
O	1062	1064	Mr	Mr	NN	B-NP
O	1064	1065	)	)	)	O
O	1066	1068	80	80	CD	B-NP
O	1068	1069	,	,	,	O
O	1069	1072	000	000	CD	B-NP
O	1073	1074	(	(	(	O
O	1074	1077	80K	80K	NN	B-NP
O	1077	1078	)	)	)	O
O	1079	1081	is	be	VBZ	B-VP
O	1082	1095	significantly	significantly	RB	I-VP
O	1096	1105	increased	increase	VBN	I-VP
O	1106	1108	in	in	IN	B-PP
O	1109	1112	all	all	PDT	B-NP
O	1113	1116	the	the	DT	I-NP
O	1117	1120	ras	ras	NN	I-NP
O	1120	1121	-	-	HYPH	B-VP
O	1121	1132	transformed	transform	VBN	B-NP
B-Cell	1133	1137	cell	cell	NN	I-NP
I-Cell	1138	1143	lines	line	NNS	I-NP
O	1143	1144	.	.	.	O

O	1145	1157	Surprisingly	Surprisingly	RB	B-ADVP
O	1157	1158	,	,	,	O
O	1159	1166	however	however	RB	B-ADVP
O	1166	1167	,	,	,	O
O	1168	1175	further	further	JJ	B-NP
O	1176	1191	phosphorylation	phosphorylation	NN	I-NP
O	1192	1194	of	of	IN	B-PP
O	1195	1199	this	this	DT	B-NP
O	1200	1207	protein	protein	NN	I-NP
O	1208	1210	on	on	IN	B-PP
O	1211	1219	addition	addition	NN	B-NP
O	1220	1222	of	of	IN	B-PP
O	1223	1230	phorbol	phorbol	NN	B-NP
O	1231	1236	ester	ester	NN	I-NP
O	1237	1240	was	be	VBD	B-VP
O	1241	1248	greatly	greatly	RB	I-VP
O	1249	1256	reduced	reduce	VBN	I-VP
O	1256	1257	.	.	.	O

B-Cell	1258	1260	Ha	Ha	NN	B-NP
I-Cell	1260	1261	-	-	HYPH	I-NP
I-Cell	1261	1264	ras	ras	NN	I-NP
I-Cell	1265	1270	cells	cell	NNS	I-NP
O	1271	1275	also	also	RB	B-ADVP
O	1276	1280	show	show	VBP	B-VP
O	1281	1285	less	less	JJR	B-NP
O	1286	1293	binding	binding	NN	I-NP
O	1294	1296	of	of	IN	B-PP
O	1297	1304	phorbol	phorbol	NN	B-NP
O	1305	1310	ester	ester	NN	I-NP
O	1311	1315	than	than	IN	B-PP
O	1316	1323	control	control	NN	B-NP
B-Cell	1324	1329	cells	cell	NNS	I-NP
O	1329	1330	,	,	,	O
O	1331	1341	suggesting	suggest	VBG	B-VP
O	1342	1346	that	that	IN	B-SBAR
O	1347	1356	elevation	elevation	NN	B-NP
O	1357	1359	of	of	IN	B-PP
O	1360	1362	DG	DG	NN	B-NP
O	1363	1369	causes	cause	VBZ	B-VP
O	1370	1377	partial	partial	JJ	B-ADJP
O	1378	1382	down	down	RB	B-ADVP
O	1382	1383	-	-	HYPH	O
O	1383	1393	regulation	regulation	NN	B-NP
O	1394	1396	in	in	IN	B-PP
O	1397	1405	addition	addition	NN	B-NP
O	1406	1408	to	to	TO	B-PP
O	1409	1419	activation	activation	NN	B-NP
O	1420	1422	of	of	IN	B-PP
O	1423	1430	protein	protein	NN	B-NP
O	1431	1437	kinase	kinase	NN	I-NP
O	1438	1439	C	C	NN	I-NP
O	1439	1440	.	.	.	O

